Sino Biopharmaceutical
Will Zeng is currently the Finance Director at Sino Biopharmaceutical Limited, where responsibilities include budget preparation, long-range planning, treasury management of approximately $4 billion in cash, and the establishment of corporate venture funds totaling RMB2 billion AUM. Previously, Zeng served as Vice President at Warburg Pincus LLC, focusing on private equity tech investments in China, and held roles at Goldman Sachs as an Associate in the Asia Special Situations Group and as an Analyst in Goldman Sachs Investment Partners, specializing in various sectors. Zeng holds a Bachelor of Science in Accounting and Finance from The Wharton School.
This person is not in any teams
This person is not in any offices
Sino Biopharmaceutical
1 followers
Sino Biopharmaceutical Limited is an investment holding company principally engaged in the medicine products business. The Company operates through three business segments. The Modernized Chinese Medicines and Chemical Medicines segment is engaged in the manufacture, sales and distribution of modernized Chinese medicine products and western medicine products. The Investment segment is engaged in long term investments. The Others segment is engaged in the provision of research and development activities and services to third parties, as well as related healthcare and hospital business. The Company is also involved in the property holding, the sales of health food, the manufacture and optometry of optical glasses, as well as the retail and wholesale of optical and auditory products through its subsidiaries.